157 related articles for article (PubMed ID: 32831036)
1. Sphingomyelin(d35:1) as a novel predictor for lung adenocarcinoma recurrence after a radical surgery: a case-control study.
Takanashi Y; Funai K; Sato S; Kawase A; Tao H; Takahashi Y; Sugimura H; Setou M; Kahyo T; Shiiya N
BMC Cancer; 2020 Aug; 20(1):800. PubMed ID: 32831036
[TBL] [Abstract][Full Text] [Related]
2. Decreased sphingomyelin (t34:1) is a candidate predictor for lung squamous cell carcinoma recurrence after radical surgery: a case-control study.
Takanashi Y; Funai K; Eto F; Mizuno K; Kawase A; Tao H; Kitamoto T; Takahashi Y; Sugimura H; Setou M; Kahyo T; Shiiya N
BMC Cancer; 2021 Nov; 21(1):1232. PubMed ID: 34789180
[TBL] [Abstract][Full Text] [Related]
3. Eight-gene signature predicts recurrence in lung adenocarcinoma.
Zhang Y; Fan Q; Guo Y; Zhu K
Cancer Biomark; 2020; 28(4):447-457. PubMed ID: 32508318
[TBL] [Abstract][Full Text] [Related]
4. The prognostic value of a Methylome-based Malignancy Density Scoring System to predict recurrence risk in early-stage Lung Adenocarcinoma.
Yang L; Zhang J; Yang G; Xu H; Lin J; Shao L; Li J; Guo C; Du Y; Guo L; Li X; Han-Zhang H; Wang C; Chuai S; Ye J; Kang Q; Liu H; Ying J; Wang Y
Theranostics; 2020; 10(17):7635-7644. PubMed ID: 32685009
[TBL] [Abstract][Full Text] [Related]
5. Micropapillary pattern of stage IIIA-N
Zeng J; Cui X; Cheng L; Chen Y; Du X; Sheng L
Future Oncol; 2020 Dec; 16(36):3075-3084. PubMed ID: 32869661
[No Abstract] [Full Text] [Related]
6. Spread through air spaces is an independent predictor of recurrence in stage III (N2) lung adenocarcinoma.
Terada Y; Takahashi T; Morita S; Kashiwabara K; Nagayama K; Nitadori JI; Anraku M; Sato M; Shinozaki-Ushiku A; Nakajima J
Interact Cardiovasc Thorac Surg; 2019 Sep; 29(3):442-448. PubMed ID: 31106332
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of adjuvant chemotherapy for lung adenocarcinoma patients with positive pleural lavage cytology findings.
Ogawa H; Uchino K; Tanaka Y; Shimizu N; Okuda Y; Tane K; Tauchi S; Nishio W; Maniwa Y; Yoshimura M
Interact Cardiovasc Thorac Surg; 2015 Jul; 21(1):34-9. PubMed ID: 25911680
[TBL] [Abstract][Full Text] [Related]
8. Epidermal Growth Factor Receptor Mutation as a Risk Factor for Recurrence in Lung Adenocarcinoma.
Hayasaka K; Shiono S; Matsumura Y; Yanagawa N; Suzuki H; Abe J; Sagawa M; Sakurada A; Katahira M; Takahashi S; Endoh M; Okada Y
Ann Thorac Surg; 2018 Jun; 105(6):1648-1654. PubMed ID: 29486179
[TBL] [Abstract][Full Text] [Related]
9. Prognostic significance and adjuvant chemotherapy survival benefits of a solid or micropapillary pattern in patients with resected stage IB lung adenocarcinoma.
Qian F; Yang W; Wang R; Xu J; Wang S; Zhang Y; Jin B; Yu K; Han B
J Thorac Cardiovasc Surg; 2018 Mar; 155(3):1227-1235.e2. PubMed ID: 29223834
[TBL] [Abstract][Full Text] [Related]
10. Limited Resection Is Associated With a Higher Risk of Locoregional Recurrence than Lobectomy in Stage I Lung Adenocarcinoma With Tumor Spread Through Air Spaces.
Kadota K; Kushida Y; Kagawa S; Ishikawa R; Ibuki E; Inoue K; Go T; Yokomise H; Ishii T; Kadowaki N; Haba R
Am J Surg Pathol; 2019 Aug; 43(8):1033-1041. PubMed ID: 31107717
[TBL] [Abstract][Full Text] [Related]
11. The prognostic significance of tumor-infiltrating lymphocytes assessment with hematoxylin and eosin sections in resected primary lung adenocarcinoma.
Kim A; Lee SJ; Ahn J; Park WY; Shin DH; Lee CH; Kwon H; Jeong YJ; Ahn HY; I H; Kim YD; Cho JS
PLoS One; 2019; 14(11):e0224430. PubMed ID: 31743333
[TBL] [Abstract][Full Text] [Related]
12. Comprehensive Study of Surgical Treated Lung Adenocarcinoma with Ground Glass Nodule Component.
Xu Y; Zheng M; Wang N; Wang R
Med Sci Monit; 2019 Nov; 25():8492-8498. PubMed ID: 31710020
[TBL] [Abstract][Full Text] [Related]
13. Pre-operative plasma cell-free circulating tumor DNA and serum protein tumor markers as predictors of lung adenocarcinoma recurrence.
Isaksson S; George AM; Jönsson M; Cirenajwis H; Jönsson P; Bendahl PO; Brunnström H; Staaf J; Saal LH; Planck M
Acta Oncol; 2019 Aug; 58(8):1079-1086. PubMed ID: 31230502
[No Abstract] [Full Text] [Related]
14. Lipid biomarkers that reflect postoperative recurrence risk in lung cancer patients who smoke: a case-control study.
Takanashi Y; Kahyo T; Hayakawa T; Sekihara K; Kawase A; Kondo M; Kitamoto T; Takahashi Y; Sato T; Sugimura H; Shiiya N; Setou M; Funai K
Lipids Health Dis; 2023 Jan; 22(1):15. PubMed ID: 36707819
[TBL] [Abstract][Full Text] [Related]
15. Adjuvant Chemotherapy Candidates in Stage I Lung Adenocarcinomas Following Complete Lobectomy.
Qian J; Xu J; Wang S; Qian F; Yang W; Zhang B; Zhang Y; Nie W; Lou Y; Lu J; Zhang X; Zhang W; Chu T; Zhong H; Fang W; Zhao H; Han B
Ann Surg Oncol; 2019 Aug; 26(8):2392-2400. PubMed ID: 31011907
[TBL] [Abstract][Full Text] [Related]
16. Outcome prediction in resectable lung adenocarcinoma patients: value of CT radiomics.
Choe J; Lee SM; Do KH; Kim S; Choi S; Lee JG; Seo JB
Eur Radiol; 2020 Sep; 30(9):4952-4963. PubMed ID: 32356158
[TBL] [Abstract][Full Text] [Related]
17. A clinical study of the prognostic factors for postoperative early recurrence in patients who underwent complete resection for pulmonary adenocarcinoma.
Sakai T; Tsushima T; Kimura D; Hatanaka R; Yamada Y; Fukuda I
Ann Thorac Cardiovasc Surg; 2011; 17(6):539-43. PubMed ID: 21881354
[TBL] [Abstract][Full Text] [Related]
18. Hypoxia‑induced galectin‑3 enhances RhoA function to activate the motility of tumor cells in non‑small cell lung cancer.
Kataoka Y; Ohshio Y; Teramoto K; Igarashi T; Asai T; Hanaoka J
Oncol Rep; 2019 Feb; 41(2):853-862. PubMed ID: 30535445
[TBL] [Abstract][Full Text] [Related]
19. A combination of preoperative CT findings and postoperative serum CEA levels improves recurrence prediction for stage I lung adenocarcinoma.
Yamazaki M; Ishikawa H; Kunii R; Tasaki A; Sato S; Ikeda Y; Yoshimura N; Hashimoto T; Tsuchida M; Aoyama H
Eur J Radiol; 2015 Jan; 84(1):178-184. PubMed ID: 25455413
[TBL] [Abstract][Full Text] [Related]
20. Prognostic and predictive role of epidermal growth factor receptor mutation in recurrent pulmonary adenocarcinoma after curative resection.
Jeon JH; Kang CH; Kim HS; Seong YW; Park IK; Kim YT
Eur J Cardiothorac Surg; 2015 Mar; 47(3):556-62. PubMed ID: 24760387
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
